NutriStack
What is happening. Valganciclovir is used heavily in immunosuppressed populations such as solid-organ and stem-cell transplant recipients, and it can deepen immune compromise through neutropenia. Live-organism probiotic supplements carry a small but real risk of bacteremia or fungemia in severely immunocompromised or neutropenic patients. The concern is not a chemical drug interaction but the heightened infection risk of ingesting live organisms in this vulnerable group.
Mechanism. Live probiotic strains (e.g., Lactobacillus, Saccharomyces boulardii) can translocate across compromised gut mucosa and cause systemic infection in neutropenic or otherwise immunosuppressed hosts. Valganciclovir-associated neutropenia and the underlying transplant immunosuppression amplify this susceptibility.
Recommendation. Immunocompromised patients (transplant recipients, those with significant neutropenia) on valganciclovir should not start live probiotic supplements without clearing it with their transplant or infectious-disease team. Fermented foods and probiotics that are safe for the general public are not automatically safe during profound immunosuppression.